D'Elia F, Zingarelli A, Palli D, Grani M
Department of Radiology, S. Donato Hospital, Arezzo, Italy.
Eur Radiol. 2000;10(12):1877-85. doi: 10.1007/s003300000537.
The aim of this study was to evaluate the accuracy of dynamic CT in the preoperative staging of gastric cancer. One hundred seven patients affected by gastric cancer diagnosed by endoscopic biopsy were prospectively staged by dynamic CT prior to tumor resection. After an oral intake of 400-600 ml of tap water and an intravenous infusion of a hypotonic agent, 200 ml of non-ionic contrast agent were administered by power injector using a biphasic technique. The CT findings were prospectively analyzed and correlated with the pathological findings at surgery. The accuracy of dynamic CT for tumor detection was 80 and 99% in early and advanced gastric cancer, respectively, with overall detection rate of 96% (103 of 107). Three early (pT1) and one advanced (pT2) cancers were undetected. Tumor stage as determined by dynamic CT agreed with pathological findings in 83 of 107 patients with an overall accuracy of 78%. The accuracy of CT in detecting increasing degrees of depth of tumor invasion when compared with pathological TNM staging was 20% (3 of 15) and 87% (80 of 92) in early and advanced cancer, respectively. The sensitivity, specificity, and accuracy of CT in the preoperative staging (pT3-pT4 vs pT1-pT2) was 93, 90, and 91.6%, respectively. The sensitivity, specificity, and accuracy of CT in assessing metastasis to regional lymph nodes was 97.2, 65.7, and 87%, respectively. Computed tomography correctly staged liver metastases in 105 of 107 patients with an overall sensitivity of 87.5% and specificity of 99 %. The sensitivity of peritoneal involvement was 30% when ascites or peritoneal nodules were absent. Our findings show that dynamic CTcan play a role in the preoperative definition of gastric cancer stage. The results can be used to optimize the therapeutic strategy for each individual patient prior to surgery, thus avoiding unnecessary intervention and allowing careful planning of extended surgery in eligible patients.
本研究的目的是评估动态CT在胃癌术前分期中的准确性。对107例经内镜活检确诊为胃癌的患者在肿瘤切除术前进行动态CT前瞻性分期。口服400 - 600 ml自来水并静脉输注低渗剂后,采用双期技术经高压注射器注入200 ml非离子型造影剂。对CT表现进行前瞻性分析,并与手术病理结果进行对照。动态CT对早期和进展期胃癌肿瘤检测的准确率分别为80%和99%,总体检测率为96%(107例中的103例)。3例早期(pT1)和1例进展期(pT2)癌症未被检测到。动态CT确定的肿瘤分期与107例患者中的83例病理结果相符,总体准确率为78%。与病理TNM分期相比,CT检测肿瘤浸润深度增加程度的准确率在早期癌症中为20%(15例中的3例),在进展期癌症中为87%(92例中的80例)。CT在术前分期(pT3 - pT4与pT1 - pT2)中的敏感性、特异性和准确率分别为93%、90%和91.6%。CT评估区域淋巴结转移的敏感性、特异性和准确率分别为97.2%、65.7%和87%。计算机断层扫描在107例患者中的105例正确分期了肝转移,总体敏感性为87.5%,特异性为99%。当无腹水或腹膜结节时,腹膜受累的敏感性为30%。我们的研究结果表明,动态CT可在胃癌术前分期中发挥作用。这些结果可用于在手术前为每个患者优化治疗策略,从而避免不必要的干预,并允许为符合条件的患者精心规划扩大手术。